Status:
UNKNOWN
Prophylactic Antibiotic Treatment During Vaginal Repair
Lead Sponsor:
Hvidovre University Hospital
Conditions:
Uterine Prolapse
Cystocele
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Prolapse of the uterus, bladder and rectum is a common condition in multiparous and/or elderly women. The number of operations for vaginal repair is increasing in Denmark, but there is no consensus or...
Eligibility Criteria
Inclusion
- Women ages 18+ with uterine prolapse grade I - II and/or cystocele and/or rectocele and/or enterocele grade I - II and/or defects of the perineal body, in whom there is medical indication for vaginal repair, but no indication for vaginal hysterectomy or transvaginal suspension of the vaginal vault after prior hysterectomy.
Exclusion
- Patients allergic to cefuroxime.
- Patients in whom a vaginal hysterectomy or a transvaginal suspension of the vaginal vault or other major surgery is planned, where prophylactic antibiotic treatment is standard.
- Patients suffering from physical or mental disorders that will not allow them to give informed consent.
- Pregnant and nursing women.
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00162604
Start Date
May 1 2005
Last Update
September 11 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hvidovre University Hospital
Hvidovre, Denmark, 2650